| Entry |
|
| Name |
Tertatolol (INN)
|
| Formula |
C16H25NO2S
|
| Exact mass |
295.1606
|
| Mol weight |
295.4402
|
| Structure |

     |
| Activity |
Antiarrhythmic agent;
Antihypertensive agent;
beta-Adrenergic blocking agent
|
| Remark |
|
| Target |
beta1-adrenergic receptor antagonist [HSA: 153] [KO: K04141]; beta2-adrenergic receptor antagonist [HSA: 154] [KO: K04142]; beta3-adrenergic receptor antagonist [HSA: 155] [KO: K04143] |
| Pathway |
|
| Interaction |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C07 BETA BLOCKING AGENTS
C07A BETA BLOCKING AGENTS
C07AA Beta blocking agents, non-selective
C07AA16 Tertatolol
D07182 Tertatolol (INN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
beta1-adrenergic receptor [HSA:153] [KO:K04141]
Tertatolol [ATC:C07AA16]
D07182 Tertatolol (INN)
beta2-adrenergic receptor [HSA:154] [KO:K04142]
Tertatolol [ATC:C07AA16]
D07182 Tertatolol (INN)
beta3-adrenergic receptor [HSA:155] [KO:K04143]
Tertatolol [ATC:C07AA16]
D07182 Tertatolol (INN)
 |
| Other DBs |
CAS: 34784-64-0 PubChem: LigandBox: NIKKAJI: |
| KCF data |
 ATOM 20
1 C8x C 28.3486 -16.0289
2 C8x C 28.3485 -14.6290
3 C8x C 27.0886 -13.9291
4 C8y C 25.8988 -14.6290
5 C8y C 25.8988 -16.0289
6 C8y C 27.0886 -16.7289
7 C1x C 24.7088 -13.8591
8 C1x C 23.4489 -14.5591
9 C1x C 23.4489 -15.9590
10 S2x S 24.6388 -16.7289
11 O2a O 27.0886 -18.1288
12 C1b C 28.2786 -18.8289
13 C1c C 29.4685 -18.1288
14 C1b C 30.7284 -18.8289
15 N1b N 31.9184 -18.1288
16 C1d C 33.1082 -18.8289
17 O1a O 29.4685 -16.7289
18 C1a C 33.8084 -17.6162
19 C1a C 32.4081 -20.0414
20 C1a C 34.2384 -19.5389
BOND 21
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 5 10 1
12 6 11 1
13 11 12 1
14 12 13 1
15 13 14 1
16 14 15 1
17 15 16 1
18 13 17 1
19 16 18 1
20 16 19 1
21 16 20 1
|